Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 20

Publication Record

Connections

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.
Moro RN, Scott NA, Vernon A, Tepper NK, Goldberg SV, Schwartzman K, Leung CC, Schluger NW, Belknap RW, Chaisson RE, Narita M, Machado ES, Lopez M, Sanchez J, Villarino ME, Sterling TR
(2018) Ann Am Thorac Soc 15: 570-580
MeSH Terms: Adolescent, Adult, Antitubercular Agents, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Infant, Newborn, Isoniazid, Latent Tuberculosis, Middle Aged, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Rifampin, Young Adult
Added March 14, 2018
0 Communities
1 Members
0 Resources
17 MeSH Terms
Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
van der Heijden YF, Karim F, Mufamadi G, Zako L, Chinappa T, Shepherd BE, Maruri F, Moosa MS, Sterling TR, Pym AS
(2017) Int J Tuberc Lung Dis 21: 670-676
MeSH Terms: Adult, Antitubercular Agents, Drug Resistance, Bacterial, Female, HIV Infections, Humans, Isoniazid, Logistic Models, Longitudinal Studies, Male, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Retrospective Studies, South Africa, Treatment Failure, Treatment Outcome, Tuberculosis
Added March 14, 2018
0 Communities
1 Members
0 Resources
17 MeSH Terms
Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S
(2017) Int J Tuberc Lung Dis 21: 286-296
MeSH Terms: Adult, Antitubercular Agents, Directly Observed Therapy, Female, Follow-Up Studies, Homeless Persons, Humans, Isoniazid, Latent Tuberculosis, Male, Medication Adherence, Multivariate Analysis, Proportional Hazards Models, Risk Factors, Sex Factors, Time Factors
Added March 14, 2018
0 Communities
1 Members
0 Resources
16 MeSH Terms
Mechanism of isoniazid-induced hepatotoxicity: then and now.
Metushi I, Uetrecht J, Phillips E
(2016) Br J Clin Pharmacol 81: 1030-6
MeSH Terms: Antitubercular Agents, Biotransformation, Chemical and Drug Induced Liver Injury, Humans, Isoniazid
Added March 30, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M
(2015) Eur Respir J 46: 1563-76
MeSH Terms: Antirheumatic Agents, Antitubercular Agents, Coinfection, Comorbidity, Disease Management, Drug Users, Emigrants and Immigrants, Evidence-Based Medicine, HIV Infections, Health Personnel, Homeless Persons, Humans, Interferon-gamma Release Tests, Isoniazid, Kidney Failure, Chronic, Latent Tuberculosis, Mass Screening, Practice Guidelines as Topic, Prisoners, Public Health, Radiography, Thoracic, Renal Dialysis, Rifampin, Risk Assessment, Silicosis, Substance-Related Disorders, Transplant Recipients, Tuberculin Test, Tumor Necrosis Factor-alpha, World Health Organization
Added February 17, 2016
0 Communities
1 Members
0 Resources
30 MeSH Terms
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME, TB Trials Consortium
(2015) Int J Tuberc Lung Dis 19: 1039-44, i-v
MeSH Terms: Adult, Antitubercular Agents, Aspartate Aminotransferases, Brazil, Canada, Case-Control Studies, Chemical and Drug Induced Liver Injury, Drug Administration Schedule, Drug Therapy, Combination, Female, Hepatitis C, Humans, Isoniazid, Latent Tuberculosis, Male, Middle Aged, Multivariate Analysis, Rifampin, Risk Factors, Spain, United States
Added February 17, 2016
0 Communities
1 Members
0 Resources
21 MeSH Terms
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
Sterling TR, Moro RN, Borisov AS, Phillips E, Shepherd G, Adkinson NF, Weis S, Ho C, Villarino ME, Tuberculosis Trials Consortium
(2015) Clin Infect Dis 61: 527-35
MeSH Terms: Adolescent, Adult, Antitubercular Agents, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Isoniazid, Latent Tuberculosis, Male, Middle Aged, Prospective Studies, Respiratory Tract Diseases, Rifampin
Added February 17, 2016
0 Communities
2 Members
0 Resources
13 MeSH Terms
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.
Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, International Maternal Pediatric and Adolescents AIDS Clinical Trials Group, Tuberculosis Trials Consortium
(2015) JAMA Pediatr 169: 247-55
MeSH Terms: Adolescent, Antitubercular Agents, Child, Child, Preschool, Drug Therapy, Combination, Female, Humans, Isoniazid, Latent Tuberculosis, Male, Rifampin, Treatment Outcome
Added February 17, 2016
0 Communities
1 Members
0 Resources
12 MeSH Terms
Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection.
Tousif S, Singh DK, Ahmad S, Moodley P, Bhattacharyya M, Van Kaer L, Das G
(2014) J Biol Chem 289: 30190-30195
MeSH Terms: Animals, Antitubercular Agents, Apoptosis, CD4-Positive T-Lymphocytes, Cell Proliferation, Cytokines, Humans, Immunosuppression, Isoniazid, Latent Tuberculosis, Lymphocyte Activation, Mice, Inbred BALB C, Mycobacterium tuberculosis, Spleen
Added January 20, 2015
0 Communities
1 Members
0 Resources
14 MeSH Terms
Risk factors for treatment default in close contacts with latent tuberculous infection.
Fiske CT, Yan FX, Hirsch-Moverman Y, Sterling TR, Reichler MR, Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team
(2014) Int J Tuberc Lung Dis 18: 421-7
MeSH Terms: Adolescent, Adult, Aged, Antitubercular Agents, Canada, Chi-Square Distribution, Contact Tracing, Female, Health Knowledge, Attitudes, Practice, Humans, Isoniazid, Latent Tuberculosis, Logistic Models, Male, Medication Adherence, Middle Aged, Multivariate Analysis, Odds Ratio, Prospective Studies, Risk Factors, Time Factors, Treatment Outcome, United States, Young Adult
Added May 29, 2014
0 Communities
1 Members
0 Resources
24 MeSH Terms